HGF-Modified Human Umbilical Cord Mesenchymal Stem Cells Rescue Impaired Ovarian Reserve Function in Chemotherapy-Induced POI Rats by Improving Angiogenesis While Decreasing Apoptosis and Fibrosis in the Ovary
To improve the effectiveness of naïve human umbilical cord MSC (HUCMSC) treatments on primary ovarian insufficiency, an exogenous gene hepatocyte growth factor (HGF) was used to modify HUCMSC.